The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque Psoriasis
Clinical trial NCT06833307 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06833307
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2026-07-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.